Dr Sotirios Bisdas

Tel: 020 344 83446
Email: sotirios.bisdas@nhs.net

Location:
National Hospital for Neurology and Neurosurgery

Specialities:
Neuroradiology

Professional background

Sotirios Bisdas is Consultant Neuroradiologist and MRI Lead in the Department of Neuroradiology at the National Hospital for Neurology in London, Senior Lecturer in Neuroradiology at the Institute of Neurology University College London, and Professor of Radiology at Eberhard Karls University in Tübingen, Germany. He finished his MD thesis in Psychiatry after joint studies at University of Athens, Greece and University of Mainz, Germany. Dr. Bisdas was trained in Radiology and Neuroradiology at Hannover Medical School, University of Frankfurt, and University of Tübingen.

He has completed a post-doctoral scholarship in Neuroradiology Research at the Medical University of South Carolina, USA. He holds a MSc. degree in “Advanced Oncology” from University of Ulm, Germany and is also Fellow of the European Society of Head and Neck Radiology. His expertise fields include advanced CT, intraoperative MRI, advanced and functional MRI and molecular MR-PET imaging in brain diseases.

He has authored more than 130 peer-reviewed publications (h-index > 30) and 7 book chapters. Currently, he is Clinical Lead of the flagship program in neurooncology, a joint initiative of the Institute of Healthcare Engineering and the National Hospital of Neurology and Neurosurgery. Dr. Bisdas serves as member of the editorial board of several leading journals in Radiology and Neuroradiology, is reviewer for leading journals in Neuroimaging, member of the Executive Committee of the European Society of Head and Neck Radiology, and member of the Head and Neck committee of the European Society of Neuroradiology.

Research interests

Neurooncology, Dementia, Neurodegeneration, Metabolic diseases, Translational and advanced neuroimaging, MRI-PET

Publications

Skardelly M, Brendle E, Noell S, Behling F, Wuttke TV, Schittenhelm J, Bisdas S, Meisner C, Rona S, Tatagiba MS, Tabatabai G. Predictors of preoperative and early postoperative seizures in patients with intra-axial primary and metastatic brain tumors: A retrospective observational single center study. Ann Neurol. 2015 Dec;78(6):917-28. doi: 10.1002/ana.24522

Bisdas S, Chadzynski GL, Braun C, Schittenhelm J, Skardelly M, Hagberg GE, Ethofer T, Pohmann R, Shajan G, Engelmann J, Tabatabai G, Ziemann U, Ernemann U, Scheffler K. MR spectroscopy for in vivo assessment of the oncometabolite 2-hydroxyglutarate and its effects on cellular metabolism in human brain gliomas at 9.4T. J Magn Reson Imaging. 2016 Oct;44(4):823-33. doi: 10.1002/jmri.25221

Hempel JM, Bisdas S, Schittenhelm J, Brendle C, Bender B, Wassmann H, Skardelly M, Tabatabai G, Vega SC, Ernemann U, Klose U.In vivo molecular profiling of human glioma using diffusion kurtosis imaging. J Neurooncol. 2017 Jan;131(1):93-101. doi: 10.1007/s11060-016-2272-0.

Ulyte A, Katsaros VK, Liouta E, Stranjalis G, Boskos C, Papanikolaou N, Usinskiene J, Bisdas S. Prognostic value of preoperative dynamic contrast-enhanced MRI perfusion parameters for high-grade glioma patients. Neuroradiology. 2016 Dec;58(12):1197-1208.

Skardelly M, Dangel E, Gohde J, Noell S, Behling F, Lepski G, Borchers C, Koch M, Schittenhelm J, Bisdas S, Naumann A, Paulsen F, Zips D, von Hehn U, Ritz R, Tatagiba MS, Tabatabai G. Prolonged Teamozolomide Maintenance Therapy in Newly Diagnosed Glioblastoma. Oncologist. 2017 May;22(5):570-575. doi: 10.1634/theoncologist.2016-0347

Bisdas S, Roder C, Ernemann U, Tatagiba MS. Intraoperative MR Imaging in Neurosurgery. Clin Neuroradiol. 2015 Oct;25 Suppl 2:237-44. doi: 10.1007/s00062-015-0443-6.

Bisdas S, Lá Fougere C, Ernemann U. Hybrid MR-PET in Neuroimaging. Clin Neuroradiol. 2015 Oct;25 Suppl 2:275-81. doi: 10.1007/s00062-015-0427-6.

Bisdas S, Smrdel U, Bajrovic FF, Surlan-Popovic K. Assessment of Progression-Free-Survival in Glioblastomas by Intratreatment Dynamic Contrast-Enhanced MRI. Clin Neuroradiol. 2016 Mar;26(1):39-45. doi: 10.1007/s00062-014-0328-0.

Rau MK, Braun C, Skardelly M, Schittenhelm J, Paulsen F, Bender B, Ernemann U, Bisdas S. Prognostic value of blood flow estimated by arterial spin labeling and dynamic susceptibility contrast-enhanced MR imaging in high-grade gliomas. J Neurooncol. 2014 Dec;120(3):557-66. doi: 10.1007/s11060-014-1586-z.

Bisdas S, Braun C, Skardelly M, Schittenhelm J, Teo TH, Thng CH, Klose U, Koh TS. Correlative assessment of tumor microcirculation using contrast-enhanced perfusion MRI and intravoxel incoherent motion diffusion-weighted MRI: is there a link between them? NMR Biomed. 2014 Oct;27(10):1184-91. doi: 10.1002/nbm.3172.

Seeger A, Braun C, Skardelly M, Paulsen F, Schittenhelm J, Ernemann U, Bisdas S. Comparison of three different MR perfusion techniques and MR spectroscopy for multiparametric assessment in distinguishing recurrent high-grade gliomas from stable disease. Acad Radiol. 2013 Dec;20(12):1557-65. doi: 10.1016/j.acra.2013.09.003.

Bisdas S, Koh TS, Roder C, Braun C, Schittenhelm J, Ernemann U, Klose U. Intravoxel incoherent motion diffusion-weighted MR imaging of gliomas: feasibility of the method and initial results. Neuroradiology. 2013 Oct;55(10):1189-96. doi: 10.1007/s00234-013-1229-7.

Bisdas S, Ritz R, Bender B, Braun C, Pfannenberg C, Reimold M, Naegele T, Ernemann U. Metabolic mapping of gliomas using hybrid MR-PET imaging: feasibility of the method and spatial distribution of metabolic changes. Invest Radiol. 2013 May;48(5):295-301. doi: 10.1097/RLI.0b013e31827188d6.

Bisdas S, Seitz O, Middendorp M, Chambron-Pinho N, Bisdas T, Vogl TJ, Hammerstingl R, Ernemann U, Mack MG. An exploratory pilot study into the association between microcirculatory parameters derived by MRI-based pharmacokinetic analysis and glucose utilization estimated by PET-CT imaging in head and neck cancer. Eur Radiol. 2010 Oct;20(10):2358-66. doi: 10.1007/s00330-010-1803-x.

GMC/GDC number: 7503143